NSRX Nasus Pharma Ltd: חוב לטווח קצר של החברה

Pressure risks from pharma behemoths are impacting the credit profile of Nasus Pharma Ltd (NSRX). Short-term debt capital, which the GURU.Markets system illustrates in this chart, demonstrates stability, with the indicator settling at 0.00. Financial stability is based on the external outsourcing of powder spray production and support via partnership grants, which mitigates dependence on insurance approval timelines for the systems.

Short-term debt measures the total credit obligations maturing within one year, determining the issuer's ability to maintain operational liquidity without the risk of default. By analyzing financial debt with a maturity of up to 12 months, an investor assesses the efficiency of working capital management, which is critical for Nasus Pharma Ltd (NSRX) when servicing costly automated production lines for nasal medications.